SOLV
Solventum Corp.
NYSE: SOLV · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$66.49
-1.51% today
Updated 2026-04-29
Market cap
$11.54B
P/E ratio
7.49
P/S ratio
1.39x
EPS (TTM)
$8.88
Dividend yield
—
52W range
$62 – $88
Volume
1.3M
Solventum Corp. (SOLV) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-9.9%
Last 4 quarters
Revenue YoY growth
-3.7%
Most recent quarter
EPS YoY growth
+11.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.9%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+5.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $1.57 | -10.3% | $75.08 | $74.20 | -1.2% |
| 2025-11-06 | $1.50 | -15.3% | $67.69 | $71.52 | +5.7% |
| 2025-08-07 | $1.69 | +0.6% | $72.57 | $73.39 | +1.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $1.75 | $1.57 | -10.3% | $2.00B | -3.7% |
| 2025-09-30 | $1.77 | $1.50 | -15.3% | $2.10B | +0.7% |
| 2025-06-30 | $1.68 | $1.69 | +0.6% | $2.16B | +3.8% |
| 2025-03-31 | $1.57 | $1.34 | -14.6% | $2.07B | +2.7% |
| 2024-12-31 | $1.50 | $1.41 | -6.0% | $2.08B | +1.9% |
| 2024-09-30 | $1.54 | $1.64 | +6.5% | $2.08B | — |
| 2024-06-30 | $1.51 | $1.56 | +3.3% | $2.08B | — |
| 2024-03-31 | $1.75 | $2.08 | +18.9% | $2.02B | — |
| 2023-12-31 | $0.00 | $2.31 | — | $2.04B | — |
Frequently asked questions
Has Solventum Corp. beaten earnings estimates?
Solventum Corp. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -9.9% over the last 4 quarters.
How does SOLV stock react to earnings?
SOLV stock has moved an average of +1.9% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Solventum Corp.'s revenue growth rate?
Solventum Corp. reported year-over-year revenue growth of -3.7% in its most recent quarter, with EPS growing +11.3% year-over-year.